Column Capital Advisors, LLC Mirati Therapeutics, Inc. Transaction History

Column Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$158.92 - $221.61 $34,326 - $47,867	-216 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $79,242 - $117,492	-489 Reduced 69.36%	216 $47,000
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $41,679 - $61,555	-368 Reduced 34.3%	705 $117,000
Q1 2020 May 11, 2020	BUY	$69.78 - $116.21 $16,119 - $26,844	231 Added 27.43%	1,073 $82,000
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $59,579 - $108,500	842 New	842 $108,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.